Daniel, Justin Kirby .

HRN: 22-63-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/01/2023
09/07/2023
IVT
340mg
Q6
Pcap C
Waiting Final Action 
09/05/2023
CEFUROXIME 750MG (VIAL)
09/05/2023
09/12/2023
IV
225mg
Q8hours
PCAP-C
Waiting Final Action 
09/05/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/05/2023
09/09/2023
PO
1.7ml
OD
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: